PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
30-Mar-2022 EUROPE’S LARGEST COMMERCIAL LAB BUILDING TO BE BUILT AT CANARY WHARF, LONDON, AS FIRST PHASE OF WORLD LEADING HEALTH AND LIFE SCIENCES CLUSTER Canary Wharf Group
30-Mar-2022 Scenic Biotech and the Barth Syndrome Foundation Announce Partnership to Explore Genetic Modifiers to a Find Tailored Treatment for the Complex Rare Disease Scenic Biotech BV
30-Mar-2022 Invizius Awarded Major Biomedical Catalyst Grant to bring Anti-Inflammatory Haemodialysis Treatment to The Clinic Invizius Limited
30-Mar-2022 atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results, Reports on R&D Progress and Highlights Strategic Focus Areas of its Innovative Mental Health Platform atai Life Sciences
30-Mar-2022 Availability of the Q1 2022 Memorandum for modelling purposes Sanofi
30-Mar-2022 CureVac and GSK Start Clinical Development of Second-Generation COVID-19 Vaccine Candidate, CV2CoV CureVac
30-Mar-2022 New analysis shows that Kesimpta®▼ (ofatumumab)-treated adults with relapsing remitting multiple sclerosis (RRMS) are not at increased risk of severe COVID-19 infections Novartis
30-Mar-2022 M1 Kliniken AG publishes preliminary figures for financial year 2021: revenue rises to € 315 million; pre-tax profit amounts to € 14.4 million M1 Kliniken AG
30-Mar-2022 Grünenthal achieves record 2021 results with double-digit growth and major investments in portfolio and pipeline Grünenthal GmbH
30-Mar-2022 HAEMATO AG - preliminary figures for the 2021 financial year: Renewed increase in sales and strong rise in earnings after disproportionate growth of the new Lifestyle and Aesthetics business unit HAEMATO AG
30-Mar-2022 PAION AG ANNOUNCES CHANGE IN MANAGEMENT BOARD PAION AG
30-Mar-2022 Eckert & Ziegler with Record Results in FY 2021 and Positive Outlook Eckert & Ziegler Strahlen- und Medizintechnik AG
30-Mar-2022 ​​​​​​​PAION AG REPORTS ON FISCAL YEAR 2021 PAION AG
30-Mar-2022 STRATEC SE: STRATEC GENERATES NEW RECORD SALES AND EARNINGS IN 2021 FINANCIAL YEAR STRATEC SE
29-Mar-2022 Formycon is acquiring the biosimilar assets FYB201 and FYB202 and strengthening its position in the global growth market of biosimilars through long-term partnership with ATHOS KG Formycon AG
29-Mar-2022 Formycon and ATHOS KG merge development activities through the acquisition of biosimilar assets in a long-term strategic partnership Formycon AG
29-Mar-2022 Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration Rentschler Biopharma
29-Mar-2022 Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration B3C newswire
29-Mar-2022 Hansa Biopharma and Medison Pharma announce marketing authorization in Israel for Idefirix® (imlifidase) for desensitization treatment of highly sensitized kidney transplant patients Hansa Biopharma
29-Mar-2022 Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy Santhera Pharmaceuticals